So we keep saying bad actors in the market and won
Post# of 36568
(Total Views: 358)
Posted On: 11/13/2020 4:53:27 PM
So we keep saying bad actors in the market and wondering why our shares outstanding keep going up???
To put that into perspective, the last transaction is $25K+5704=/187,219 is an average price of $0.164/share. No wonder they can sell at $0.19 and make money. Come on Joe.
Quote:
On February 28, 2020, we closed a financial transaction under a securities purchase agreement with three investors pursuant to which we sold a series of convertible notes bearing interest at 9.5% per year in the principal amount in the aggregate of $281,600. The purchase price of the notes in the aggregate were $256,600 and the remaining $25,600 of principal amount in the aggregate represents original issue discount. Subject to certain ownership limitations, the note will be convertible at the option of the holder at any time into shares of our common stock the note will be convertible at the option of the holder at any time into shares of our common stock at a conversion price equal to the lesser of
• A price determined as of the date of closing; and
• 80% of the lowest volume weighted average trading price of the common stock on the ten days prior to (and including) the date a notice of conversion is received.
All of the following are subsequent to July 31, 2020:
On August 7, 2020, we converted $54,222 of principal, $750 in fees, $87,274 in penalties and $250 of interest into 400,000 shares of common stock.
On August 11, 2020, we converted $46,746 in penalties into 140,496 shares of common stock.
On August 18, 2020, we converted $25,000 of principal into 76,219 shares of common stock.
On August 21, 2020, we converted $31,667 of principal, $750 in fees and $6,162 of interest into 120,558 shares of common stock.
On August 25, 2020, we converted $25,000 of principal into 76,200 shares of common stock.
On August 31, 2020, we converted $35,000 of principal into 134,615 shares of common stock.
On September 9, 2020, we converted $93,867 of principal and $5,809 of interest into 408,504 shares of common stock.
On September 10, 2020, we converted $40,000 of principal into 163,934 shares of common stock.
On September 15, 2020, we converted $70,800 of principal into 300,000 shares of common stock.
On September 16, 2020, we converted $18,000 of principal and $750 of fees into 86,805 shares of common stock.
On September 18, 2020, we converted $50,000 of principal into 265,957 shares of common stock.
On September 22, 2020, we converted $30,000 of principal into 164,473 shares of common stock.
On September 25, 2020, we converted $30,000 of principal into 210,674 shares of common stock.
On September 25, 2020, we converted $15,867 of principal and $750 of fees into 116,690 shares of common stock.
On September 25, 2020, we converted $60,000 of principal and $750 of fees into 421,348 shares of common stock.
On September 29, 2020, we converted $30,000 of principal into 210,674 shares of common stock.
On September 29, 2020, we converted $64,080 of principal into 450,000 shares of common stock.
76
On October 5, 2020, we converted $50,000 of principal into 351,123 shares of common stock.
On October 5, 2020, we converted $4,500 of interest and $32,000 of penalties into 256,320 shares of common stock.
On October 6, 2020, we converted $35,000 of principal and $750 of fees into 251,053 shares of common stock.
On October 7, 2020, we converted $40,000 of principal and $22,000 of interest into 435,393 shares of common stock.
On October 7, 2020, we converted $15,120 of principal and $74,877 of interest into 632,000 shares of common stock.
On October 13, 2020, we converted $25,000 of principal and $5,704 of interest into 187,219 shares of common stock.
The securities discussed under this Item 15 were issued in reliance on the exemption from registration provided in Section 4(a)(2) of the Securities Act for transactions not involving a public offering.
To put that into perspective, the last transaction is $25K+5704=/187,219 is an average price of $0.164/share. No wonder they can sell at $0.19 and make money. Come on Joe.
(3)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Disclaimer: Of course, all of this is my opinion and you should not make any investment decisions based on my opinion. I have not received any non-public information.